OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors

What You Should Know:  - OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing

Related Keywords

Alexandria ,Al Iskandariyah ,Egypt ,Neville Sanjana ,Cancer Research Institute ,Fusion Fund ,Overt Bio Secures ,Optimize Cell Therapy ,Should Know ,Overt Bio ,Alexandria Venture Investments ,Civilization Ventures ,Cancer Research ,Data Driven Approach ,Cell Therapy ,Mat Legut ,Pioneering Technologies ,Parallel Genetic Screening ,Cell Multiomics ,Biology Techniques ,